Parliamentary Search

Written question asked by Baroness Redfern (Conservative) on Monday, 22 June 2026, in the House of Lords. It was due for an answer on Monday, 6 July 2026. It was answered by Baroness Merron (Labour) on Thursday, 2 July 2026 on behalf of the Department of Health and Social Care.

Pancreatic Cancer: Clinical Trials

Question

To ask His Majesty's Government what plans they have to expand clinical trials for pancreatic cancer by automatically linking eligible patients to available trials.

Answer

The Department is committed to ensuring that all patients, including those with pancreatic cancer, have access to cutting-edge clinical trials and innovative, lifesaving treatments.

As set out in our National Cancer Plan, the Government will implement the Rare Cancers Act 2026, including Section 3 of the act, which will involve developing a service to ensure rare cancer patients, including those with pancreatic cancer, can be automatically contacted about clinical trials.

The Government is currently scoping the technical requirements for this service and identifying a suitable route for delivery, before a development project is commenced. This will allow data sharing from the National Disease Registration Service to the National Institute for Health and Care Research’s Be Part of Research registry tool.

Implementing the provisions of the Rare Cancers Act will make it easier for clinical trials on pancreatic cancer to take place in England.

Secondary information

Type
Written question
Reference
HL1192
Session
2026-27
Subjects
Clinical trials Pancreatic cancer
Link
View this Written question on www.parliament.uk